Rapport Therapeutics, Inc. Common Stock (RAPP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.55B
Last updated: Nov 17, 2026 at 11:05 AM ET
Rapport Therapeutics, Inc. Common Stock (RAPP) Earnings: Report Dates and Results
Rapport Therapeutics, Inc. Common Stock (RAPP) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Rapport Therapeutics, Inc. Common Stock reported EPS of -$0.84, above the -$1.21 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
RAPP has an expected report date of Mar 8, 2027.
Earnings History
Of the 10 quarters below that had an estimate, RAPP beat 7 and missed 3. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 150.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.84 | -$1.21 | -$1.36 - -$1.08 | +30.58% | Beat | N/A | 12 | 0 up, 3 down | Nov 4, 2026 |
| Jun 30, 2026 | -$1.19 | -$0.93 | -$1.04 - -$0.90 | -27.96% | Miss | N/A | 7 | 1 up, 4 down | Aug 5, 2026 |
| Mar 31, 2026 | -$0.42 | -$0.71 | -$1.06 - -$0.45 | +40.85% | Beat | N/A | 6 | 3 up, 1 down | May 7, 2026 |
| Dec 31, 2025 | -$0.72 | -$0.67 | -$0.82 - -$0.55 | -6.78% | Miss | N/A | 7 | 1 up, 0 down | Mar 10, 2026 |
| Sep 30, 2025 | -$0.71 | -$0.73 | -$0.87 - -$0.63 | +2.74% | Beat | N/A | 5 | 1 up, 1 down | Nov 6, 2025 |
| Jun 30, 2025 | -$0.75 | -$0.87 | N/A | +13.79% | Beat | N/A | 3 | 1 up, 0 down | Aug 7, 2025 |
| Mar 31, 2025 | -$0.68 | -$0.74 | N/A | +8.11% | Beat | N/A | 2 | 0 up, 1 down | May 8, 2025 |
| Dec 31, 2024 | -$0.57 | -$0.70 | N/A | +18.57% | Beat | N/A | 3 | 0 up, 0 down | Mar 11, 2025 |
| Sep 30, 2024 | -$0.50 | -$0.52 | N/A | +3.85% | Beat | N/A | 3 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$1.70 | -$0.68 | N/A | -150.00% | Miss | N/A | N/A | N/A | Aug 8, 2024 |
| Mar 31, 2024 | -$1.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 29, 2024 |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$2.45 | N/A |
| Jun 30, 2026 | -$1.61 | N/A |
| Dec 31, 2025 | -$2.86 | N/A |
| Dec 31, 2024 | -$3.89 | N/A |
Frequently Asked Questions About RAPP
When is Rapport Therapeutics, Inc. Common Stock's next earnings date?
Rapport Therapeutics, Inc. Common Stock's next earnings report is expected for Mar 8, 2027.
Did RAPP beat earnings estimates last quarter?
Yes. Rapport Therapeutics, Inc. Common Stock reported EPS of -$0.84 for the quarter ended Sep 30, 2026, above the -$1.21 estimate, a 30.58% surprise.
What EPS do analysts expect from RAPP next quarter?
The consensus EPS estimate for Rapport Therapeutics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$1.03 from 18 analysts, with estimates from -$1.51 to -$0.84.
How often does RAPP beat earnings estimates?
Rapport Therapeutics, Inc. Common Stock beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +9.99%.
RAPP pages: Overview, Earnings, Forecast, Competitors